Publications by authors named "Caroline Ho"

Claim this Profile
T
The Feasibility and Reliability of the Test of Gross Motor Development (TGMD-3) for Children with Disabilities in Regional Australia: A Pragmatic Pilot Study.
Georgina L Clutterbuck, Caroline Ho, Genevieve M Dwyer

Phys Occup Ther Pediatr· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Single High-Dose Liposomal Amphotericin B for Induction Treatment of Cryptococcal Meningitis and Histoplasmosis in People With HIV: A Systematic Review and Meta-analysis.
HeeEun Kang, John P Uy, Caroline C Ho, Heather B Blunt, Natalie B Riblet

Open Forum Infect Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction of a microRNA-mRNA Regulatory Network in Cytogenetically Normal Acute Myeloid Leukemia Patients.
Ezalia Esa, Ariwibawa Kasmani Hashim, Elsa Haniffah Mejia Mohamed, Zubaidah Zakaria, Alifah Nadia Abu Hassan, Caroline Siew-Ling Ho, Peng-Choon Lau

Genet Test Mol Biomarkers· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Based Drug Design and Synthesis of PI3Kα-Selective Inhibitor (PF-06843195).
Hengmiao Cheng, Suvi T M Orr, Simon Bailey, Alexei Brooun, Ping Chen, Hong Shen, Hovhannes J Gukasyan, Caroline Ho

J Med Chem· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of function of the melanocortin 2 receptor accessory protein 2 is associated with mammalian obesity.
Masato Asai, Shwetha Ramachandrappa, Maria Joachim, Yuan Shen, Rong Zhang, Caroline Ho, Joel N Hirschhorn

Science· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells.
Joshua Bliesath, Nanni Huser, Mayuko Omori, Daniel Bunag, Chris Proffitt, Caroline Ho

Cancer Lett· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CK2 inhibitor CX-4945 suppresses DNA repair response triggered by DNA-targeted anticancer drugs and augments efficacy: mechanistic rationale for drug combination therapy.
Adam Siddiqui-Jain, Joshua Bliesath, Diwata Macalino, Mayuko Omori, Nanni Huser, Caroline B Ho, Daniel D Von Hoff

Mol Cancer Ther· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein kinase CK2 modulates IL-6 expression in inflammatory breast cancer.
Denis Drygin, Caroline B Ho, Mayuko Omori, Joshua Bliesath, Chris Proffitt

Biochem Biophys Res Commun· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer.
Fabrice Pierre, Peter C Chua, Sean E O'Brien, Adam Siddiqui-Jain, Pauline Bourbon, Caroline Ho

Mol Cell Biochem· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel potent pyrimido[4,5-c]quinoline inhibitors of protein kinase CK2: SAR and preliminary assessment of their analgesic and anti-viral properties.
Fabrice Pierre, Sean E O'Brien, Mustapha Haddach, Pauline Bourbon, Michael K Schwaebe, Caroline Ho

Bioorg Med Chem Lett· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth.
Denis Drygin, Amy Lin, Josh Bliesath, Caroline B Ho, Sean E O'Brien

Cancer Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and SAR of 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer.
Fabrice Pierre, Peter C Chua, Sean E O'Brien, Adam Siddiqui-Jain, Pauline Bourbon, Caroline Ho

J Med Chem· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy.
Adam Siddiqui-Jain, Denis Drygin, Nicole Streiner, Peter Chua, Fabrice Pierre, Caroline Ho

Cancer Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parental authority, nurturance, and two-dimensional self-esteem.
Romin W Tafarodi, Nicole Wild, Caroline Ho

Scand J Psychol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis.
Denis Drygin, Adam Siddiqui-Jain, Sean O'Brien, Michael Schwaebe, Amy Lin, Caroline B Ho, Daniel Von Hoff

Cancer Res· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Audit of pediatric hematology-oncology outpatients in Kuala Lumpur.
Bina Sharine Menon, Eni Juraida, Hishamshah Ibrahim, Mahfuzah Mohamed, Caroline Ho

Southeast Asian J Trop Med Public Health· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cultural differences in the relationship between parenting and children's behavior.
Caroline Ho, Deborah N Bluestein, Jennifer M Jenkins

Dev Psychol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The phosphatidylinositol 3-kinase inhibitor, PX-866, is a potent inhibitor of cancer cell motility and growth in three-dimensional cultures.
Amy L Howes, Gary G Chiang, Elizabeth S Lang, Caroline B Ho, Garth Powis

Mol Cancer Ther· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoreduction for intraocular retinoblastoma in Malaysia.
Bina Sharine Menon, Eni Juraida, Joseph Alagaratnam, Mahfuzah Mohammad, Hishamshah Ibrahim, Caroline Ho

J Pediatr Hematol Oncol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold.
Zachary A Knight, Gary G Chiang, Peter J Alaimo, Denise M Kenski, Caroline B Ho, Kevan M Shokat

Bioorg Med Chem· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluation of synthetic viridins derived from C(20)-heteroalkylation of the steroidal PI-3-kinase inhibitor wortmannin.
Peter Wipf, Daniel J Minion, Robert J Halter, Margareta I Berggren, Caroline B Ho

Org Biomol Chem· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychopathology in the parents of boys with gender identity disorder.
Kenneth J Zucker, Susan J Bradley, Dahlia N Ben-Dat, Caroline Ho, Laurel Johnson

J Am Acad Child Adolesc Psychiatry· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis